Updated Jun. 3, 2013 at 10:57 a.m.

Premium Lock After Duke study, FDA to reconsider GSK diabetes drug Avandia

Published: 2013-06-03 09:37:00
Updated: 2013-06-03 10:57:19

Avandia Avandia

The former blockbuster diabetes pill which was subjected to major safety restrictions in 2010 may not be as dangerous as once thought, according to the latest analysis of the much-debated GlaxoSmithKline drug....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Scroll